Literature DB >> 24927120

Mechanisms of transcriptional regulation by WT1 (Wilms' tumour 1).

Eneda Toska1, Stefan G E Roberts.   

Abstract

The WT1 (Wilms' tumour 1) gene encodes a zinc finger transcription factor and RNA-binding protein that direct the development of several organs and tissues. WT1 manifests both tumour suppressor and oncogenic activities, but the reasons behind these opposing functions are still not clear. As a transcriptional regulator, WT1 can either activate or repress numerous target genes resulting in disparate biological effects such as growth, differentiation and apoptosis. The complex nature of WT1 is exemplified by a plethora of isoforms, post-translational modifications and multiple binding partners. How WT1 achieves specificity to regulate a large number of target genes involved in diverse physiological processes is the focus of the present review. We discuss the wealth of the growing molecular information that defines our current understanding of the versatility and utility of WT1 as a master regulator of organ development, a tumour suppressor and an oncogene.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24927120      PMCID: PMC8887836          DOI: 10.1042/BJ20131587

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  203 in total

1.  Angioblast-mesenchyme induction of early kidney development is mediated by Wt1 and Vegfa.

Authors:  Xiaobo Gao; Xing Chen; Mary Taglienti; Bree Rumballe; Melissa H Little; Jordan A Kreidberg
Journal:  Development       Date:  2005-11-16       Impact factor: 6.868

2.  The Wilms' tumor gene Wt1 is required for normal development of the retina.

Authors:  Kay-Dietrich Wagner; Nicole Wagner; Valerie P I Vidal; Gunnar Schley; Dagmar Wilhelm; Andreas Schedl; Christoph Englert; Holger Scholz
Journal:  EMBO J       Date:  2002-03-15       Impact factor: 11.598

3.  Wilms' tumor 1 and Dax-1 modulate the orphan nuclear receptor SF-1 in sex-specific gene expression.

Authors:  M W Nachtigal; Y Hirokawa; D L Enyeart-VanHouten; J N Flanagan; G D Hammer; H A Ingraham
Journal:  Cell       Date:  1998-05-01       Impact factor: 41.582

4.  WT1-interacting protein and ZO-1 translocate into podocyte nuclei after puromycin aminonucleoside treatment.

Authors:  Maribel Rico; Amitava Mukherjee; Martha Konieczkowski; Leslie A Bruggeman; R Tyler Miller; Shenaz Khan; Jeffrey R Schelling; John R Sedor
Journal:  Am J Physiol Renal Physiol       Date:  2005-03-29

5.  Wt1 ablation and Igf2 upregulation in mice result in Wilms tumors with elevated ERK1/2 phosphorylation.

Authors:  Qianghua Hu; Fei Gao; Weihua Tian; E Cristy Ruteshouser; Yaqing Wang; Alexander Lazar; John Stewart; Louise C Strong; Richard R Behringer; Vicki Huff
Journal:  J Clin Invest       Date:  2010-12-01       Impact factor: 14.808

6.  WT1 regulates the development of the posterior taste field.

Authors:  Yankun Gao; Eneda Toska; Dane Denmon; Stefan G E Roberts; Kathryn F Medler
Journal:  Development       Date:  2014-05-06       Impact factor: 6.868

7.  Wilms' tumor protein WT1 as an ovarian transcription factor: decreases in expression during follicle development and repression of inhibin-alpha gene promoter.

Authors:  S Y Hsu; M Kubo; S Y Chun; F G Haluska; D E Housman; A J Hsueh
Journal:  Mol Endocrinol       Date:  1995-10

8.  Induction of WT1 (Wilms' tumor gene)-specific cytotoxic T lymphocytes by WT1 peptide vaccine and the resultant cancer regression.

Authors:  Yoshihiro Oka; Akihiro Tsuboi; Tetsuya Taguchi; Tadashi Osaki; Taiichi Kyo; Hiroko Nakajima; Olga A Elisseeva; Yusuke Oji; Manabu Kawakami; Kazuhiro Ikegame; Naoki Hosen; Satoshi Yoshihara; Fei Wu; Fumihiro Fujiki; Masaki Murakami; Tomoki Masuda; Sumiyuki Nishida; Toshiaki Shirakata; Shin-Ichi Nakatsuka; Ayako Sasaki; Keiko Udaka; Hiroo Dohy; Katsuyuki Aozasa; Shinzaburo Noguchi; Ichiro Kawase; Haruo Sugiyama
Journal:  Proc Natl Acad Sci U S A       Date:  2004-09-13       Impact factor: 11.205

9.  WT1 promotes invasion of NSCLC via suppression of CDH1.

Authors:  Chen Wu; Weiyou Zhu; Jing Qian; Shaohua He; Changping Wu; Yijiang Chen; Yongqian Shu
Journal:  J Thorac Oncol       Date:  2013-09       Impact factor: 15.609

10.  Repression of Pax-2 by WT1 during normal kidney development.

Authors:  G Ryan; V Steele-Perkins; J F Morris; F J Rauscher; G R Dressler
Journal:  Development       Date:  1995-03       Impact factor: 6.868

View more
  48 in total

Review 1.  Regulation of breast cancer metastasis signaling by miRNAs.

Authors:  Belinda J Petri; Carolyn M Klinge
Journal:  Cancer Metastasis Rev       Date:  2020-09       Impact factor: 9.264

2.  G-quadruplex forming region within WT1 promoter is selectively targeted by daunorubicin and mitoxantrone: A possible mechanism for anti-leukemic effect of drugs.

Authors:  Saeedeh Ghazaey Zidanloo; Abasalt Hosseinzadeh Colagar; Hossein Ayatollahi; Zahra Bagheryan
Journal:  J Biosci       Date:  2019-03       Impact factor: 1.826

Review 3.  Growing evidence suggests WT1 effects in the kidney development are modulated by Hsp70/NO interaction.

Authors:  Luciana Mazzei; Walter Manucha
Journal:  J Nephrol       Date:  2016-04-08       Impact factor: 3.902

Review 4.  A role of WT1 in cell division and genomic stability.

Authors:  Jayasha Shandilya; Stefan G E Roberts
Journal:  Cell Cycle       Date:  2015       Impact factor: 4.534

5.  DNA methylation and leukemia susceptibility in China: Evidence from an updated meta-analysis.

Authors:  Danjie Jiang; Yirun Li; Qingxiao Hong; Yusheng Shen; Chunjing Xu; Yan Xu; Huangkai Zhu; Dongjun Dai; Guifang Ouyang; Shiwei Duan
Journal:  Mol Clin Oncol       Date:  2016-07-12

6.  Wilms tumor protein-dependent transcription of VEGF receptor 2 and hypoxia regulate expression of the testis-promoting gene Sox9 in murine embryonic gonads.

Authors:  Karin M Kirschner; Lina K Sciesielski; Katharina Krueger; Holger Scholz
Journal:  J Biol Chem       Date:  2017-10-17       Impact factor: 5.157

7.  Modulation of apolipoprotein L1-microRNA-193a axis prevents podocyte dedifferentiation in high-glucose milieu.

Authors:  Abheepsa Mishra; Kamesh Ayasolla; Vinod Kumar; Xiqian Lan; Himanshu Vashistha; Rukhsana Aslam; Ali Hussain; Sheetal Chowdhary; Shadafarin Marashi Shoshtari; Nitpriya Paliwal; Waldemar Popik; Moin A Saleem; Ashwani Malhotra; Leonard G Meggs; Karl Skorecki; Pravin C Singhal
Journal:  Am J Physiol Renal Physiol       Date:  2018-01-10

8.  Podocyte-Specific Induction of Krüppel-Like Factor 15 Restores Differentiation Markers and Attenuates Kidney Injury in Proteinuric Kidney Disease.

Authors:  Yiqing Guo; Jesse Pace; Zhengzhe Li; Avi Ma'ayan; Zichen Wang; Monica P Revelo; Edward Chen; Xiangchen Gu; Ahmed Attalah; Yaqi Yang; Chelsea Estrada; Vincent W Yang; John C He; Sandeep K Mallipattu
Journal:  J Am Soc Nephrol       Date:  2018-08-24       Impact factor: 10.121

9.  Implications of the Wilms' Tumor Suppressor Wt1 in Cardiomyocyte Differentiation.

Authors:  Nicole Wagner; Marina Ninkov; Ana Vukolic; Günseli Cubukcuoglu Deniz; Minoo Rassoulzadegan; Jean-François Michiels; Kay-Dietrich Wagner
Journal:  Int J Mol Sci       Date:  2021-04-21       Impact factor: 5.923

10.  Wilms' tumor 1 (WT1) promotes ovarian cancer progression by regulating E-cadherin and ERK1/2 signaling.

Authors:  Yun Han; Chao Song; Tingting Zhang; Qianqian Zhou; Xiaoqian Zhang; Jing Wang; Boqun Xu; Xuesen Zhang; Xiaoqiu Liu; Xiaoyan Ying
Journal:  Cell Cycle       Date:  2020-09-07       Impact factor: 4.534

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.